Steroid Choice for Rheumatoid Arthritis in Pregnancy
Introduction to Steroid Use
- The American College of Rheumatology recommends that both prednisolone and methylprednisolone are equally safe and appropriate for treating rheumatoid arthritis during pregnancy, as they are both minimally transferred to the fetus and carry no increased risk of major birth defects 1, 2, 3
- Prednisolone and methylprednisolone share the same favorable placental metabolism profile, limiting fetal exposure to approximately 10% of the maternal dose, making them the preferred glucocorticoids for treating maternal conditions during pregnancy 1, 2, 3
Steroid Safety and Efficacy
- Both drugs are FDA pregnancy category B with no evidence of teratogenicity in humans at therapeutic doses 1
- Neither drug increases the risk of major congenital malformations when used appropriately during pregnancy 4, 5
Dosing Strategy
- Maintain the lowest effective dose, ideally ≤5 mg/day of prednisone-equivalent, and taper when possible 4, 5, 6
- If higher doses are required for disease control, consider adding pregnancy-compatible steroid-sparing agents to reduce glucocorticoid burden 4, 7
Risks and Contraindications
- Doses above 20 mg/day prednisone-equivalent should be avoided when possible due to increased maternal-fetal risks including gestational diabetes, pregnancy-associated osteoporosis, serious maternal infections, and preterm birth 4, 5
- Never use fluorinated corticosteroids for routine RA management in pregnancy, as they cross the placenta extensively and are reserved only for fetal indications like lung maturation 1, 2, 3